A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

• Main Authors: Shen He (Author), Yimin Yu (Author), Jingjing Huang (Author), Jiahui Yin (Author), Yajuan Niu (Author), Yazhou Lu (Author), Bin Wu (Author), Maosheng Fang (Author), Xue Wang (Author), Zhiping Tao (Author), Lehua Li (Author), Kan Li (Author), Yan Li (Author), Xiujuan Ding (Author), Yifeng Shen (Author), Huafang Li (Author)
• Format: Book
• Published: SAGE Publishing, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Almost one-third of patients with major depressive disorder (MDD) do not respond to conventional antidepressants, and new treatments for MDD are urgently needed. Objectives: This phase IIb clinical trial was designed to evaluate the efficacy and safety of Anyu Peibo capsules in the treat...